AAAAAA
Results: 1-25/44
Authors:
Kahrilas, PJ
Citation: Pj. Kahrilas, Introduction: evolution of management strategies and opportunities for esomeprazole (Nexium (R)), EUR J GASTR, 13, 2001, pp. S1-S2
Authors:
Kahrilas, PJ
Citation: Pj. Kahrilas, Risk management for gastroenterologists, EUR J GASTR, 13, 2001, pp. S9-S10
Authors:
Kahrilas, PJ
Citation: Pj. Kahrilas, The changed role for oesophageal pH monitoring, EUR J GASTR, 13, 2001, pp. S29-S30
Authors:
Kahrilas, PJ
Citation: Pj. Kahrilas, Session 3: Initial therapy - A strategic overview, EUR J GASTR, 13, 2001, pp. S63-S65
Authors:
Kahrilas, PJ
Citation: Pj. Kahrilas, Needed outcomes studies, EUR J GASTR, 13, 2001, pp. S84-S85
Authors:
Kahrilas, PJ
Citation: Pj. Kahrilas, Surgical therapy for reflux disease, J AM MED A, 285(18), 2001, pp. 2376-2378
Authors:
Stevoff, C
Rao, S
Parsons, W
Kahrilas, PJ
Hirano, I
Citation: C. Stevoff et al., EUS and histopathologic correlates in eosinophilic esophagitis, GASTROIN EN, 54(3), 2001, pp. 373-377
Authors:
Kahrilas, PJ
Citation: Pj. Kahrilas, Will impedence testing rewrite the book on GERD?, GASTROENTY, 120(7), 2001, pp. 1862-1864
Authors:
Hirano, I
Tatum, RP
Shi, GX
Sang, Q
Joehl, RJ
Kahrilas, PJ
Citation: I. Hirano et al., Manometric heterogeneity in patients with idiopathic achalasia, GASTROENTY, 120(4), 2001, pp. 789-798
Authors:
Song, CW
Lee, SJ
Jeen, YT
Chun, HJ
Um, SH
Kim, CD
Ryu, HS
Hyun, JH
Lee, MS
Kahrilas, PJ
Citation: Cw. Song et al., Inconsistent association of esophageal symptoms, psychometric abnormalities and dysmotility, AM J GASTRO, 96(8), 2001, pp. 2312-2316
Authors:
Jones, MP
Sloan, SS
Rabine, JC
Ebert, CC
Huang, CF
Kahrilas, PJ
Citation: Mp. Jones et al., Hiatal hernia size is the dominant determinant of esophagitis presence andseverity in gastroesophageal reflux disease, AM J GASTRO, 96(6), 2001, pp. 1711-1717
Authors:
DiRe, C
Shi, GX
Manka, M
Kahrilas, PJ
Citation: C. Dire et al., Manometric characteristics of the upper esophageal sphincter recorded witha microsleeve, AM J GASTRO, 96(5), 2001, pp. 1383-1389
Authors:
Richter, JE
Kahrilas, PJ
Johanson, J
Maton, P
Breiter, JR
Hwang, C
Marino, V
Hamelin, B
Levine, JG
Citation: Je. Richter et al., Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: A randomized controlled trial, AM J GASTRO, 96(3), 2001, pp. 656-665
Authors:
Richter, JE
Kahrilas, PJ
Sontag, SJ
Kovacs, TOG
Huang, BD
Pencyla, JL
Citation: Je. Richter et al., Comparing lansoprazole and omeprazole in onset of heartburn relief: Results of a randomized, controlled trial in erosive esophagitis patients, AM J GASTRO, 96(11), 2001, pp. 3089-3098
Authors:
Pandolfino, JE
Kahrilas, PJ
Citation: Je. Pandolfino et Pj. Kahrilas, Extraesophageal manifestations of gastroesophageal reflux disease, CLIN GAS, 2001, pp. 177-192
Authors:
Kahrilas, PJ
Citation: Pj. Kahrilas, Strategies for medical management of reflux disease, BEST PR RES, 14(5), 2000, pp. 775-791
Authors:
Logemann, JA
Pauloski, BR
Rademaker, AW
Colangelo, LA
Kahrilas, PJ
Smith, CH
Citation: Ja. Logemann et al., Temporal and biomechanical characteristics of oropharyngeal swallow in younger and older men, J SPEECH L, 43(5), 2000, pp. 1264-1274
Authors:
Kahrilas, PJ
Citation: Pj. Kahrilas, Maximizing outcome of extraesophageal reflux disease, AM J M CARE, 6(16), 2000, pp. S876-S882
Authors:
Hogan, WJ
Kahrilas, PJ
Fass, R
Kaplan-Machlis, B
Morreale, AP
Citation: Wj. Hogan et al., Efficient and effective treatment of gastroesophageal reflux disease, FORMULARY, 35, 2000, pp. S3-S25
Authors:
Pandolfino, JE
Kahrilas, PJ
Citation: Je. Pandolfino et Pj. Kahrilas, Smoking and gastro-oesophageal reflux disease, EUR J GASTR, 12(8), 2000, pp. 837-842
Authors:
Kahrilas, PJ
Citation: Pj. Kahrilas, Esophageal motility disorders: Current concepts of pathogenesis and treatment, CAN J GASTR, 14(3), 2000, pp. 221-231
The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease
Authors:
Kahrilas, PJ
Quigley, EMM
Castell, DO
Spechler, SJ
Citation: Pj. Kahrilas et al., The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease, ALIM PHARM, 14(11), 2000, pp. 1503-1509
Authors:
Kahrilas, PJ
Falk, GW
Johnson, DA
Schmitt, C
Collins, DW
Whipple, J
D'Amico, D
Hamelin, B
Joelsson, B
Citation: Pj. Kahrilas et al., Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial, ALIM PHARM, 14(10), 2000, pp. 1249-1258
Authors:
Kahrilas, PJ
Lin, SZ
Manka, M
Shi, GX
Joehl, RJ
Citation: Pj. Kahrilas et al., Esophagogastric junction pressure topography after fundoplication, SURGERY, 127(2), 2000, pp. 200-208
Authors:
Tatum, RP
Shi, GX
Manka, MA
Brasseur, JG
Joehl, RJ
Kahrilas, PJ
Citation: Rp. Tatum et al., Bolus transit assessed by an esophageal stress test in postfundoplication dysphagia, J SURG RES, 91(1), 2000, pp. 56-60